TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company . The firm focuses on discovering and developing novel small molecule
2021-04-08
2021-03-25 About the TetraLogic Pharmaceuticals Corp. stock forecast. As of 2021 February 07, Sunday current price of TLOG stock is 0.0350$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. TetraLogic Pharmaceuticals Corp. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame.
- Terapeuta online za darmo
- Hitta elektriker stockholm
- Felaktig faktura moms
- Ebs sweden ab
- Mariestads maskin och energi
- Klumpfot
- Vetenskaper olika
The firm focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases 2 dagar sedan · Find the latest TETRALOGIC PHARMACEUTICALS CORP (TLOG) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-08 · TetraLogic Pharmaceuticals Corp (TLOG) TetraLogic Pharmaceuticals Corp. (TLOG) Nasdaq Listed. Nasdaq 100. Data is currently not available. $0.0351.
Get TetraLogic Pharmaceuticals Corp (TLOG:OTCPK) real-time stock quotes, news, price and financial information from CNBC.
The firm focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases. Its products include Birinapant and SHAPE.
Apr 8, 2014 TetraLogic Pharmaceuticals Acquires Shape Pharmaceuticals for Shape Pharmaceuticals, Inc. is developing a novel, topical HDAC inhibitor,
View the TLOG U.S. Securities and Exchange Commission reporting information. TetraLogic Pharmaceuticals General Information Description.
TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. More Details Risk Analysis
Birinapant är ett SMAC mimetikum som förvärvades från TetraLogic Pharmaceuticals Corporation (TetraLogic) 2016 och som därefter utvecklats av Medivir. Medivir omförhandlade nyligen avtalet med TetraLogic så att den ersättning Medivir är skyldig att erlägga till TetraLogic är baserad på Medivirs faktiska framtida intäkter.
Insr insurance group
tetralogic pharmaceuticals corporation, tetralogic research and development corporation and medivir ab dated as of november 2, 2016 asset purchase agreement this asset purchase TetraLogic Pharmaceuticals - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘TetraLogic Pharmaceuticals - Product Pipeline Review - 2015’, provides an overview of the TetraLogic Pharmaceuticals’s pharmaceutical research and development focus.
May 7, 2015 Shares in TetraLogic Pharmaceuticals declined more than 35% upon the announcement that the company was suspending enrolment in a
Forskningsbolaget Medivir har omförhandlat sitt avtal gällande ersättningsmodell och nivåer för birinapant med TetraLogic Pharmaceuticals.
Impact coatings delårsrapport
redovisning kontering
schema jensen gymnasium
tomas lundqvist
stockholm-hällefors buss
elgiganten ägare
folktandvården sundsvall priser
för in vitro diagnostikutrustningen (IVD) Drug Response Predictor har de förvärvade onkologiprogrammen från TetraLogic Pharmaceuticals
Other Classes: 548/458, 435/375 . International A pharmaceutical composition comprising the compound having the formula: wherein R5 is —CH2CH3, TetraLogic Pharmaceuticals (Nasdaq: TLOG) is a clinical-stage biopharmaceutical company focused on discovering, acquiring and developing novel product candidates to treat cancer and infectious TetraLogic Pharmaceuticals Corp.
Robert musil agathe
tesla semi
- Dikotomi böjning
- Mattelek förskola
- Entrepreneur stories 4 inspiration podcast
- Upphandlingsrattslig tidskrift
- Robinson martin melin massage
- Merix exchange göteborg
- Spotify ägare kina
- Kalmar regionsjukhus
- Kronoberg häktet adress
- Hur mycket lon far jag ut
Forskningsbolaget Medivir har omförhandlat sitt avtal gällande ersättningsmodell och nivåer för birinapant med TetraLogic Pharmaceuticals.
KARO PHARMA AB. Sverige. i USA av FDA (U.S.
About the TetraLogic Pharmaceuticals Corp. stock forecast. As of 2021 April 12, Monday current price of TLOG stock is 0.0440$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).
TetraLogic Pharmaceuticals General Information Description.
The Company discovers and develops small molecule peptide-mimetic drugs for the treatment of cancers. TetraLogic Pharmaceuticals Corp (TLOG:PKN) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.